Q1 25 EPS
$0.44
MISS 1.54%
Est. $0.45
Q1 25 Revenue
$1.35B
MISS 3.02%
Est. $1.40B
vs S&P Since Q1 25
-41.1%
TRAILING MARKET
SEM -7.9% vs S&P +33.2%
Market Reaction
Did SEM Beat Earnings? Q1 2025 Results
Select Medical delivered a tale of two segments in Q1 2025, with a 33.3% surge in earnings per share to $0.44 masking a meaningful deterioration in its largest business line. Total revenue grew 2.4% year-over-year to $1.35 billion, but the headline n… Read more Select Medical delivered a tale of two segments in Q1 2025, with a 33.3% surge in earnings per share to $0.44 masking a meaningful deterioration in its largest business line. Total revenue grew 2.4% year-over-year to $1.35 billion, but the headline numbers tell only part of the story. The critical illness recovery hospital segment, the company's biggest revenue driver, saw sales fall 2.9% to $637.03 million while Adjusted EBITDA collapsed 25.3% to $86.65 million, compressing margins from 17.7% to 13.6%. Carrying the other side of the ledger, the rehabilitation hospital segment posted a 15.7% revenue jump to $307.39 million as the company expanded to 35 hospitals. Much of the EPS strength came from a 28.5% decline in interest expense following the November 2024 Concentra spinoff rather than core operating momentum, a distinction investors will weigh against management's updated full-year 2025 outlook, which calls for revenue of $5.30 billion to $5.50 billion and Adjusted EBITDA of $510 million to $530 million, with EPS guidance of $1.09 to $1.19 reaffirmed.
Key Takeaways
- • Rehabilitation hospital segment revenue grew 15.7% driven by expansion to 35 hospitals from 33, 6.9% growth in admissions, and 6.6% increase in revenue per patient day
- • Interest expense declined 28.5% to $29.1 million, boosting net income despite lower operating income
- • Critical illness recovery hospital segment EBITDA margin declined from 17.7% to 13.6% due to lower revenue per patient day, fewer admissions, and increased cost of services
- • Income tax expense declined 19.6% contributing to 21.5% growth in income from continuing operations
- • Cost of services increased 4.6% year-over-year, outpacing 2.4% revenue growth
SEM YoY Financials
Q1 2025 vs Q1 2024, source: SEC Filings
SEM Revenue by Segment
With YoY comparisons, source: SEC Filings
SEM Earnings Trends
SEM vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
SEM EPS Trend
Earnings per share: estimate vs actual
SEM Revenue Trend
Quarterly revenue: estimate vs actual
SEM Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 MISS | $0.46 | $0.36 | -21.00% | $1.42B | +0.49% |
| Q4 25 MISS FY | $0.23 | $0.16 | -31.06% | $1.40B | +2.39% |
| FY Full Year | $1.23 | $1.16 | -5.55% | $5.45B | +0.60% |
| Q3 25 BEAT | $0.15 | $0.23 | +48.67% | $1.36B | +2.53% |
| Q2 25 BEAT | $0.24 | $0.32 | +35.19% | $1.34B | -0.66% |
| Q1 25 MISS | $0.45 | $0.44 | -1.54% | $1.35B | -3.02% |